Correlative Light-Electron Microscopy Shows RGD-Targeted ZnO Nanoparticles Dissolve in the Intracellular Environment of Triple Negative Breast Cancer Cells and Cause Apoptosis with Intratumor Heterogeneity
AuthorsOthman, Basmah A.
Bharath, Anil A.
Porter, Alexandra E.
KAUST DepartmentBiological and Environmental Sciences and Engineering (BESE) Division
Cell Migration and Signaling Laboratory
Division of Biological and Environmental Sciences and Engineering
MetadataShow full item record
AbstractZnO nanoparticles (NPs) are reported to show a high degree of cancer cell selectivity with potential use in cancer imaging and therapy. Questions remain about the mode by which the ZnO NPs cause cell death, whether they exert an intra- or extracellular effect, and the resistance among different cancer cell types to ZnO NP exposure. The present study quantifies the variability between the cellular toxicity, dynamics of cellular uptake, and dissolution of bare and RGD (Arg-Gly-Asp)-targeted ZnO NPs by MDA-MB-231 cells. Compared to bare ZnO NPs, RGD-targeting of the ZnO NPs to integrin αvβ3 receptors expressed on MDA-MB-231 cells appears to increase the toxicity of the ZnO NPs to breast cancer cells at lower doses. Confocal microscopy of live MDA-MB-231 cells confirms uptake of both classes of ZnO NPs with a commensurate rise in intracellular Zn2+ concentration prior to cell death. The response of the cells within the population to intracellular Zn2+ is highly heterogeneous. In addition, the results emphasize the utility of dynamic and quantitative imaging in understanding cell uptake and processing of targeted therapeutic ZnO NPs at the cellular level by heterogeneous cancer cell populations, which can be crucial for the development of optimized treatment strategies.
CitationCorrelative Light-Electron Microscopy Shows RGD-Targeted ZnO Nanoparticles Dissolve in the Intracellular Environment of Triple Negative Breast Cancer Cells and Cause Apoptosis with Intratumor Heterogeneity 2016 Advanced Healthcare Materials
JournalAdvanced Healthcare Materials
- Targeted Cancer Therapy: Correlative Light-Electron Microscopy Shows RGD-Targeted ZnO Nanoparticles Dissolve in the Intracellular Environment of Triple Negative Breast Cancer Cells and Cause Apoptosis with Intratumor Heterogeneity (Adv. Healthcare Mater. 11/2016).
- Authors: Othman BA, Greenwood C, Abuelela AF, Bharath AA, Chen S, Theodorou I, Douglas T, Uchida M, Ryan M, Merzaban JS, Porter AE
- Issue date: 2016 Jun
- ZnO Nanoparticles Treatment Induces Apoptosis by Increasing Intracellular ROS Levels in LTEP-a-2 Cells.
- Authors: Wang C, Hu X, Gao Y, Ji Y
- Issue date: 2015
- Intracellular accumulation dynamics and fate of zinc ions in alveolar epithelial cells exposed to airborne ZnO nanoparticles at the air-liquid interface.
- Authors: Mihai C, Chrisler WB, Xie Y, Hu D, Szymanski CJ, Tolic A, Klein JA, Smith JN, Tarasevich BJ, Orr G
- Issue date: 2015 Feb
- Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
- Authors: Zhang T, Prasad P, Cai P, He C, Shan D, Rauth AM, Wu XY
- Issue date: 2017 Jun
- Systematic investigation of the physicochemical factors that contribute to the toxicity of ZnO nanoparticles.
- Authors: Mu Q, David CA, Galceran J, Rey-Castro C, Krzemiński L, Wallace R, Bamiduro F, Milne SJ, Hondow NS, Brydson R, Vizcay-Barrena G, Routledge MN, Jeuken LJ, Brown AP
- Issue date: 2014 Apr 21